ARCHIVES

NCI “Can’t Justify Size Of Intramural Program”

This article is from The Cancer Letter archive.

Vol. 21 No. 19 | May 12, 1995

Download PDF Visit The Full Archive

Related Articles

Agreement Nears On New Guidelines For Center Grants

November 14, 1980

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Beefed Up Centers Subcommittee Meets On Core Guidelines

December 2, 1977

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

RFA: Native American Women’s Cancer Initiative

July 9, 1993

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001